Gracell Biotechnologies Inc.
GRCL
|
|
| |
|
| Trading Volume | 6,417,173 |
|
|
10.35 - 2.43 |
| Market Cap Full | $ 3.5B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | - | 2.1% | -19.1% | -61.3% |
| Q2 | - | - | 104.8% | 135% |
| Q3 | - | - | -24.4% | -41.5% |
| Q4 | - | - | 287.6% | -28.6% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 1.8 | 0.3 | - | - | - | - | - | - | - | - | - | - |
| 2023 | |||||||||||
| -6.5 | -6.5 | -7.5 | -6.5 | 57.5 | 39.1 | -1.1 | -13 | -12.2 | 16.7 | 44.9 | 106.2 |
| 2022 | |||||||||||
| -41.2 | -10.1 | -26.7 | -3.9 | 42.7 | 71.3 | -35.8 | -28.9 | 28.3 | -0.9 | 1.9 | -29.2 |
| 2021 | |||||||||||
| - | 9.7 | -32.3 | -20.9 | 10.8 | -3.7 | -4.4 | -16.1 | 33 | -22.9 | -27.7 | -22 |
| 2020 | |||||||||||
| - | - | - | - | - | - | - | - | - | - | - | - |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.4 | -0.4 | -0.3 | 0 |
| Q2 | -0.3 | -0.3 | -0.2 | 0 |
| Q3 | -0.1 | -0.4 | -0.3 | 0 |
| Q4 | 0 | -0.3 | -0.3 | 0 |
| A | -0.75 | -0.3 | -0.2 | -0.4 |